Adrian V.S. Hill is Professor of Human Genetics and Director of the Jenner Institute at Oxford University. He leads research programmes in both the genetics of susceptibility to tropical infectious diseases and in vaccine development. The Jenner Institute links human vaccine research at the University of Oxford with veterinary vaccine development at The Pirbright Institute and the UK Animal and Plant Health Agency.
Dr. Howard L. Kaufman has been a leading authority on tumor immunotherapy for the treatment of melanoma. He pioneered the development of recombinant viral vectors encoding eukaryotic tumor antigens and immune modulatory genes for cancer therapy and has conducted over 50 cancer vaccine and immunotherapy clinical trials. Dr. Kaufman has maintained an NIH-funded laboratory in tumor immunology for over 15 years.
Who should attend? Academic, industry and government representatives interested in vaccine research.
Goal: To improve knowledge of Canadian vaccine accomplishments while supporting investments for vaccine research and development.
Session topics include:
- emerging disease vaccines
- cancer vaccines
- global health vaccines: parasites and TB
- vaccine technologies
There will also be a panel discussion on funding of vaccine research and development in Canada.